淋病人类挑战模型的可接受性,以加速英国男性的疫苗开发

C Firth1, K Emary1, A Stuart1

  • 1The Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.

Vaccine
|March 14, 2025
PubMed
概括

招募男性参加淋病疫苗研究是可行的. 解决耻辱和提供公平补偿是参与受控性传播感染 (STIs) 人类感染研究的关键.